Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-08-05
1987-05-26
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549292, 562501, 560119, 560256, 514824, C07D30930, A61K 31365
Patent
active
046686991
ABSTRACT:
Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) or (II): ##STR1## wherein: n is 1 to 5;
REFERENCES:
patent: 4346227 (1982-08-01), Terahara et al.
patent: 4376863 (1983-03-01), Lam
patent: 4410629 (1983-10-01), Terahara et al.
patent: 4448979 (1984-05-01), Terahara et al.
patent: 4517373 (1985-05-01), Terahara et al.
Hoffman William F.
Scolnick Edward
Smith Robert L.
Dinner D. L.
DiPrima Joseph F.
Hollrah Glennon H.
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Novel HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-704149